Heart-lung transplantation—global activity between 2003 and 2023, indications and outcomes
HLTx is currently performed in about one-quarter of reporting countries, accounting for just 1.3%-1.6% of thoracic transplant volume. Despite lower early survival, younger HLTx recipients who survive the initial year show promising long-term outcomes.
Authors
- Jens Gottlieb (ORCID: https://orcid.org/0000-0002-9540-9022)
- Anna Holm (ORCID: https://orcid.org/0000-0002-2582-4984)
- Charlotte Sybrecht
Institutions
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Medizinische Hochschule Hannover (DE)
- German Center for Lung Research (DE)
- Universities of Giessen and Marburg Lung Center (DE)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-10-07
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100405
- Citations
- 3
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 6.02